Ronald Kirk Huntsman is CEO at Vivos Therapeutics, Inc. (VVOS). They have made 9 open-market trades across 1 company since 2020, most recently 2023-06-20.
CIK 0001835498
9 open-market purchases totalling $116K since 2020, never a sale. Across 9 scored buys the stock is up 0.4% at ninety days, and 3.1 points behind the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VVOS | 57,521 | $6K |
Shares reported on the most recent Form 4, priced at the 2023-06-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -4.5% | +0.4% | +0.4% |
| Alpha | -62.1% | -1.5% | -3.1% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VVOS | BUY | 2023-06-20 | 2023-06-20 | $0.53 | $7K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2023-06-15 | 2023-06-20 | $0.54 | $8K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2023-06-14 | 2023-06-15 | $0.49 | $5K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2022-12-23 | 2022-12-28 | $0.50 | $10K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2022-05-31 | 2022-06-03 | $1.96 | $24K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2021-09-21 | 2021-09-22 | $4.31 | $22K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2021-08-17 | 2021-08-18 | $3.00 | $15K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2021-05-25 | 2021-05-25 | $5.38 | $22K | -4.5% | +0.4% | +0.4% |
| VVOS | BUY | 2020-12-11 | 2020-12-14 | $8.50 | $4K | -4.5% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.